RT Journal Article SR Electronic T1 Attributable mortality of vancomycin resistance in ampicillin-resistant Enterococcus faecium bacteremia in Denmark and the Netherlands: a matched cohort study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.05.10.20049783 DO 10.1101/2020.05.10.20049783 A1 Wouter C. Rottier A1 Mette Pinholt A1 Akke K. van der Bij A1 Magnus Arpi A1 Sybrandus N. Blank A1 Marrigje H. Nabuurs-Franssen A1 Gijs J.H.M. Ruijs A1 Matthijs Tersmette A1 Jacobus M. Ossewaarde A1 Rolf H. Groenwold A1 Henrik Westh A1 Marc J.M. Bonten A1 on behalf of the Dutch VRE Bacteremia Investigators and the Danish Collaborative Bacteraemia Network (DACOBAN) YR 2020 UL http://medrxiv.org/content/early/2020/05/15/2020.05.10.20049783.abstract AB Background In many European hospitals, ampicillin-resistant Enterococcus faecium (ARE) is endemic, while outbreaks of vancomycin-resistant E. faecium (VRE), belonging to the same genetic lineage, are increasingly reported. We studied the attributable mortality due to vancomycin resistance in patients with E. faecium bacteremia and evaluated whether this is mediated by a delay in appropriate antibiotic therapy.Methods In a retrospective matched cohort study, patients with VRE bacteremia occurring between 2009 and 2014 in 20 Dutch and Danish hospitals were matched to patients with ARE bacteremia, on hospital, ward, length of hospital stay prior to bacteremia, and age. The risk ratio (RR) for 30-day mortality contrasting VRE with ARE was estimated with further analytic control for confounding factors.Results In all, 63 VRE and 234 ARE episodes were matched (36 and 130 for the Netherlands and 27 and 104 for Denmark). Crude 30-day mortality was 27% and 38% for ARE in the Netherlands and Denmark, respectively, and 33% and 48% for VRE in the respective countries. The adjusted RR for 30-day mortality for VRE was 1.54 (95% confidence interval (CI) 1.06-2.25). Although appropriate therapy was initiated later for VRE than for ARE bacteremia, this did not appear to mediate the increased mortality risk.Conclusions Compared to ARE bacteremia, VRE bacteremia was associated with higher 30-day mortality. One explanation for this association would be increased virulence of VRE, although both phenotypes belong to the same well-characterized core genomic lineage. Alternatively, it may be the result of unmeasured confounding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a research grant from the Netherlands Organisation for Health Research and Development [grant number 205200007] to W.C.R.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearch data are not shared.